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ABSTRACT
Objective: To evaluate the role of prostate basal cell staining in diagnosing Gleason score 6 prostate cancer. 
Material & Method: During research period, we collected 20 medical records and paraffin block specimens of 
Gleason score 6 prostatic adenocarcinoma patients. Specimens were taken from prostate needle biopsy. 
Demographic data and PSA level were extracted from medical records. Basal cells were detected by 
immunohistochemical staining for antikeratin 34β-E12 on paraffin block specimens analyzed by an experienced 
pathologist. Positive results suggest a benign lesion. Results: Mean age is 70 ± 6,5 years. Mean prostate volume 
and PSA level was 52±17cc and 25±21 ng/ml. Three specimens (15%) showed presence of basal cells on 
antikeratin 34β-E12 staining, which indicated benign lesions. Leucocyturia was found in all patients of this 
group. There was a significant association between PSA level and antikeratin 34β-E12 staining (p=0,03) 
Conclusions: 15 % cases of prostatic cancer Gleason score 6 still showed basal cell existence. 
Immunohistochemical staining of basal cell should be considered in suspicious cases of prostatic cancer.  
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INTRODUCTION
Histopathological examination is the gold 
standard in diagnosis of prostatic adenocarcinoma. 
Diagnosis  of  Gleason score  6  pros ta t ic  
adenocarcinoma by needle biopsy is challenging. 
Approximately 11% of needle biopsy specimens 
stained with hematoxylin and eosin were 
misinterpreted as prostatic adenocarcinoma. 
Inadequately collected specimens may cause 
misinterpretation of the nucleus cytoplasm ratio and 
nucleoli of the prostate cells. Some benign lesions, 
such as adenosis, basal cell hyperplasia, atrophy, and 
prostatitis, may also mimic malignant growth. 
Detection of basal cells using cytokeratin 903 staining 
in suspicious lesions from needle biopsy is an 
invaluable method in diagnosing prostatic 
adenocarcinoma. The absence of basal cells in 
prostatic acini is an essential characteristic of prostatic 
1,2
adenocarcinoma.
Shah et al and Acimovic et al (2005) confirmed 
the existence of prostate basal cell in 1,1% prostate 
cancer specimens, using antikeratin 34β-E12 
3
staining.  Therefore, basal cell staining is believed to 
increase specificity of histopathological evaluation of 
4,5
prostate cancer.
OBJECTIVE
To evaluate the role of prostate basal cell staining 
in diagnosing Gleason score 6 prostate cancers.
MATERIAL  & METHOD
We collected all specimens of Gleason score 6 
prostatic adenocarcinoma taken by needle biopsy, 
within January 2009 - September 2009. Demographic 
data, PSA level, and prostate volume was extracted 
from medical records. Immunohistochemical staining 
to cytokeratin 903 was performed to all specimens 
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RESULTS
Mean age was 70 ± 6,5 years. Mean prostate 
volume and PSA level was 52 ± 17cc and 25 ± 21 
ng/ml. Three specimens stained positive for 
cytokeratin 903, which indicates benign lesions. All 
patients also had leucocyturia on urinalysis. 
Figure1. Age distribution.  
Figure 3. Prostate volume distribution.
A significant association was found between PSA 
level and antikeratin 34β-E12 staining (p=0,04).
Figure 2. PSA level distribution.
using antikeratin 34β-E12. Positive result suggests a 
benign lesion. Histopathological evaluation was 
performed by an uropathologist.
False positive rate was evaluated using a 2x2 table. 
Mann-Whitney test was used to evaluate the 
association between PSA level and antikeratin 34β-
E12 staining. Statistical analysis was performed using 
SPSS 16.
Table 1.  Association between antikeratin 34β E12 staining 
and PSA level group.
PSA group
Total
Antikeratin
3 -E 12β
( + ) 3 
100,0% 
( ?) 17 
100,0% 
Total 20 
0 
ng/ml
,0% 
2 
11,8% 
2 
10,0% 
10-20 
ng/ml
0 
 ,0% 
10 
58,8% 
10 
50,0% 
>20
ng/ml
3
100,0% 
5
29,4% 
8
40,0% 100,0% 
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In multivariate analysis, a significant association 
between age, prostate volume, leucocyturia with 
antikeratin 34β-E12 staining (p>0,05).
Figure 4. Gleason score 6 prostatic adenocarcinoma on HE 
staining.
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Figure 5. Gleason score 6 prostatic adenocarcinoma on 
antikeratin 34β-E12 staining (positive staining).
Figure 6. Gleason score 6 prostatic adeno-carcinoma on 
antikeratin 34β-E12 staining (negative staining).
DISCUSSION
Accurate diagnosis of prostatic adenocarcinoma 
is a crucial part in management. Histopathological 
appearance of prostate cancer may mimic benign 
lesions, therefore more specific examination is 
needed. Imunohistochemical examination can help a 
pathologist to identify prostate basal cells, an 
important marker in diagnosis of prostate cancer. 
15% (3) cases of needle biopsy specimens were 
falsely diagnosed as Gleason score 6 prostatic 
carcinoma on HE staining. All patients had 
leucocyturia, which may be associated with infection 
of the urinary tract, including the prostate. Many 
evidence suggest that infection may mimic prostatic 
histopathological appearance, which may lead to 
misdiagnosis. Therefore, immunohistochemical 
staining of cytokeratin 903 in prostatic basal cell is 
needed to increase accuracy of Gleason score 6 
prostate cancer diagnosis, especially in patients with 
leucocyturia.
CONCLUSION
Presence of basal cells was demonstrated in 15% 
cases of Gleason score 6 prostate cancer. 
Nasution: Evaluation of prostate basal cell by cytokeratin 903
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Immunohistochemical staining of basal cell should be 
considered in suspicious cases of prostate cancer.
